
Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development with AI Endpoints
Altis Labs raises US$25 million in Series A financing to enhance AI models for oncology trials and expand their commercial efforts.


















